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Abstract
We have previously demonstrated that neutrophil recruitment to the heart 
following myocardial infarction (MI) is enhanced in mice lacking 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1) that regenerates active glucocorticoid within 
cells from intrinsically inert metabolites. The present study aimed to identify the 
mechanism of regulation. In a mouse model of MI, neutrophil mobilization to blood 
and recruitment to the heart were higher in 11β-HSD1-deficient (Hsd11b1−/−) relative 
to wild-type (WT) mice, despite similar initial injury and circulating glucocorticoid. In 
bone marrow chimeric mice, neutrophil mobilization was increased when 11β-HSD1 was 
absent from host cells, but not when absent from donor bone marrow-derived cells. 
Consistent with a role for 11β-HSD1 in ‘host’ myocardium, gene expression of a subset of 
neutrophil chemoattractants, including the chemokines Cxcl2 and Cxcl5, was selectively 
increased in the myocardium of Hsd11b1−/− mice relative to WT. SM22α-Cre directed 
disruption of Hsd11b1 in smooth muscle and cardiomyocytes had no effect on neutrophil 
recruitment. Expression of Cxcl2 and Cxcl5 was elevated in fibroblast fractions isolated 
from hearts of Hsd11b1−/− mice post MI and provision of either corticosterone or of the 
11β-HSD1 substrate, 11-dehydrocorticosterone, to cultured murine cardiac fibroblasts 
suppressed IL-1α-induced expression of Cxcl2 and Cxcl5. These data identify suppression 
of CXCL2 and CXCL5 chemoattractant expression by 11β-HSD1 as a novel mechanism 
with potential for regulation of neutrophil recruitment to the injured myocardium, and 
cardiac fibroblasts as a key site for intracellular glucocorticoid regeneration during acute 
inflammation following myocardial injury.
Introduction
Ischemic cell death associated with myocardial infarction 
(MI) prompts the recruitment and activation of immune 
cells to ensure repair (Epelman & Mann 2012, Frangogiannis 
2012). Neutrophils are recruited early, removing necrotic 
tissue and matrix debris from the damaged myocardium 
(Frangogiannis 2012, Yan  et  al.  2013), but they are also 
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important to ensure transition to repair. Macrophage 
polarization toward a reparative phenotype in the 
healing myocardium is promoted by neutrophil-derived 
gelatinase-associated lipocalin and by efferocytosis of 
apoptotic neutrophils (Chen et al. 2014, Horckmans et al. 
2017). However, neutrophil recruitment requires tight 
regulation to minimize the risk of tissue damage due 
to release of pro-inflammatory mediators, matrix 
metalloproteinases and oxygen free radicals (Jordan et al. 
1999, Ma et al. 2013).
Systemic glucocorticoid concentration is increased 
by the activation of the hypothalamic–pituitary–
adrenal axis early after MI (Morrison et al. 1976). Active 
glucocorticoid (predominantly cortisol in man and 
corticosterone in rats and mice) is also regenerated within 
cells from intrinsically inert metabolites (cortisone and 
11-dehydrocorticosterone 11-DHC) by the intracellular 
enzyme 11β-hydroxysteroid dehydrogenase type 1 
(11β-HSD1). Cell-specific enhancement of 11βHSD1 
availability by IL-1 (Tomlinson  et  al. 2001) and by 
glucocorticoid (Chapman  et  al. 2006) serves to locally 
amplify glucocorticoid action during inflammation (Sun 
& Myatt 2003, Chapman et al. 2013a). When 11β-HSD1 is 
deficient or inhibited, neutrophil-driven inflammation is 
increased in experimental sterile peritonitis (Gilmour et al. 
2006), arthritis (Coutinho et al. 2012, Nanus et al. 2015) 
and carrageenan-induced pleurisy (Chapman et al. 2006, 
Coutinho et al. 2012). In an earlier study, we found that 
early neutrophil recruitment to the injured myocardium 
also increases in 11β-HSD1-deficient mice following 
induction of MI by coronary artery ligation, and this is 
associated with increased pro-reparative macrophage 
polarization and reduced detrimental remodeling 
(McSweeney  et  al. 2010). This suggests a key role for 
intracellular corticosteroid regeneration in regulating 
neutrophil recruitment to the injured heart, but the 
underlying mechanisms are unknown (Gray et al. 2017).
Neutrophil recruitment requires mobilization from the 
bone marrow to the blood in response to chemoattractant 
signals from injured tissue, as well as adhesion to 
endothelial cells and migration into the tissue. Previous 
studies have focused on the latter, showing that neutrophil 
11β-HSD1 activity is increased during inflammation and 
that this activity regulates the expression of L-selectin, 
CD11b and annexin (Kardon et al. 2008, Coutinho et al. 
2016). However, the heart releases chemoattractants that 
include interleukin (IL)-1 and the CXCR2-activating 
ELR chemokines such as CXCL1 (KC), CXCL2 (MIP-2α; 
macrophage inflammatory protein 2-alpha) and CXCL5 
(LIX), that are essential for neutrophil recruitment 
after injury (Chandrasekar  et  al. 2001, Kobayashi 2008, 
Frangogiannis 2012). Recent studies have also identified 
growth-differentiation factor-15 (GDF-15) as a novel 
inhibitor of neutrophil recruitment post MI (Kempf et al. 
2011). Regulation of the expression of these key molecules 
is a potential additional mechanism through which 
glucocorticoid, generated in myocardial cells by 11β-
HSD1, suppresses neutrophil recruitment after injury.
11β-HSD1 is expressed by a number of cells found in 
the heart with the potential to release chemoattractants 
following injury, including cardiomyocytes 
(Mazancova  et  al. 2005), vascular smooth muscle 
(Hatakeyama  et  al. 2001), mast cells (Coutinho  et  al. 
2013) and resident macrophages (Gilmour  et  al. 2006) 
and fibroblasts (Sun & Myatt 2003). In a recent study 
(White et al. 2016), we reported that 11β-HSD1 deletion 
in cardiac and vascular smooth muscle has no effect on 
chronic remodeling post MI, suggesting that these cells 
are not likely to be a key site for regulation of myocardial 
inflammation and repair.
The present study aimed to investigate whether 
changes in myocardial neutrophil content are 
accompanied by changes in neutrophil mobilization from 
bone marrow to the blood; whether myocardial neutrophil 
chemoattractant expression post MI is influenced by 
11β-HSD1 availability and key cellular sites of 11β-HSD1 
expression that determine neutrophil recruitment.
Materials and methods
Mice
Experiments used adult male mice with global deficiency 
on a C57BL/6 genetic background (Hsd11b1−/−) 
(Kipari et al. 2013) (Supplementary Fig. 1, see section on 
supplementary data given at the end of this article), with 
WT C57BL/6 mice used as controls. Mice with deletion 
targeted to vascular smooth muscle and cardiomyocytes 
(White et al. 2016) (Hsd11b1fl/flSm22α-Cre+; Hsd11b1CVCre+) 
were generated by crossing Sm22α-Cre mice with 
Hsd11b1fl/fl mice, homozygous for a ‘floxed’ allele of 
Hsd11b1 (generated by Artemis Pharmaceuticals, Cologne, 
Germany), directly onto a C57BL/6J background. LoxP 
sites flanked exon 3 of the mouse Hsd11b1 gene. Excision 
of this exon results in a ‘null allele’ by ‘out-of-frame 
splicing’ from exon 2 to exon 4. Controls were Hsd11b1fl/fl 
(Cre−; Hsd11b1CVCre−) littermates.
Male mice (6–14 weeks old) were bred and maintained 
in conventional barrier unit facilities at the University 
of Edinburgh. Experimental and control mice, WT or 
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Cre− littermates (Hsd11b1CVCre−), were age matched. All 
animal work was compliant with IACUC guidelines, 
conducted in accordance with the UK Government 
Animals (Scientific Procedures) Act 1986 and was 
approved by the University of Edinburgh Animal Welfare 
and Ethical Review Board.
Generation of chimeric mice
Chimeric mice were created by exposing WT and 
Hsd11b1−/− mice to a single lethal dose of 10.5 Gy radiation. 
This was followed by i.v. injection of 1 × 107 donor bone 
marrow cells harvested from the femurs and tibias of WT 
or Hsd11b1−/− mice. To control for the effects of irradiation, 
‘irradiation control’ animals were generated wherein 
WT recipients received WT bone marrow. In ‘host KO’ 
animals, Hsd11b1−/− recipients received WT donor cells, so 
that all quickly dividing cells prone to radiation, including 
bone marrow leucocytes, were replaced by cells with a 
WT phenotype, but host cells were Hsd11b1 deficient. 
In ‘BMKO’ animals, WT recipients received Hsd11b1−/− 
bone marrow, resulting in Hsd11b1−/− neutrophils and WT 
radio-resistant host tissue. Chimeric animals were housed 
under pathogen-free conditions in individually ventilated 
cages and given Baytril antibiotic (2.5%) in the drinking 
water for 1 week before and 4 weeks after bone marrow 
transplantation. Chimeras were allowed to recover for 
8 weeks before appropriate reconstitution was confirmed 
by flow cytometry of tail vein blood and CAL surgery 
was performed.
Coronary artery ligation (CAL) surgery
CAL surgery for induction of myocardial infarction was 
carried out as we have previously described (White et al. 
2016). Mice were anesthetized with isoflurane (2%), which 
was maintained for the length of the procedure, and 
received appropriate analgesia (buprenorphine 0.05 mg/
kg s.c. before surgery and 24 h later). The trachea was 
intubated and the lungs were ventilated mechanically at 
120 strokes/min. The left thorax was opened at the fourth 
intercostal space, before the left descending coronary 
artery ligated with a 6.0-prolene suture. After closing 
the thorax, animals received oxygen in the absence of 
anesthesia until fully conscious.
Plasma troponin measurement
Tail vein blood was collected from mice 24 h post 
CAL surgery, following administration of analgesic 
(buprenorphine 0.05 mg/kg s.c.), into 10 mM sodium 
citrate buffer and centrifuged at 2400 g for 10 min at 4°C 
to produce a plasma phase. Cardiac Troponin I (Tn-I) was 
measured in the plasma using the mouse high-sensitivity 
Tn-I ELISA kit according to the manufacturers instructions 
(Life Diagnostics, Staffordshire, UK).
Tissue collection and immunohistochemistry
Mice were terminally anesthetized with saline containing 
ketamine at 50 mg/kg and medetomidine at 0.5 mg/kg 
by i.p. injection. Hearts were perfusion fixed by infusing 
heparinized saline (10 IU/mL heparin), and then 10% 
formalin at physiological pressure (100 mmHg) via the 
abdominal aorta. Hearts were placed in 10% formalin 
overnight before processing to wax and paraffin embedding 
for GR1+ immunohistochemistry (IHC; antibody used in 
Table 1) as described previously (McSweeney et al. 2010). 
For quantification, sections were tiled at ×40 magnification 
(Image Pro6.2, Stereologer Analyser 6 MediaCybernetics). 
The % area stained with the GR1 antibody (dark brown) 
was calculated within the infarct and border area.
Corticosterone radioimmunoassay
Plasma corticosterone at the diurnal nadir, one day post 
surgery, was measured by radioimmunoassay as described 
previously (Kotelevtsev et al. 1997).
Flow cytometry of blood and bone marrow cells
Mice were killed by cervical dislocation, and bone 
marrow cells were harvested by flushing the femur and 
tibia with phosphate buffered saline (PBS; Thermo Fisher) 
as described previously (Kipari et al. 2013). Erythrocytes 
were lysed (red blood cell lysis buffer; Sigma-Aldrich). 
0.5 × 106 singly-suspended cells were then blocked with 
10% mouse serum for 20 min on ice, and then incubated 
for 30 min on ice with appropriate dilutions of antibodies 
of interest (Table 1) in PBS containing 10% mouse serum. 
Blood was collected in 10 mM sodium citrate buffer and 
antibodies were added directly to the blood. Intracellular 
staining of 11β-HSD1 in blood neutrophils was carried 
out as described previously (De Sousa Peixoto et al. 2008). 
Cells were fixed and permeabilized using a kit (Fix and 
Perm, Invitrogen; Thermo Fisher) to facilitate intracellular 
immunostaining of 11βHSD1. Cells were then washed in 
PBS before acquisition and analysis (BD FACS LSR Fortessa 
and FlowJo software; Oregon, USA). The gating strategy for 
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analyzing blood neutrophils is shown in Supplementary 
Fig. 2.
Fibroblast isolation post MI
Mice were terminally anesthetized with saline containing 
ketamine at 50 mg/kg and medetomidine at 0.5 mg/kg by 
i.p. injection. Heart tissue was digested before fibroblast 
isolation. Briefly, infarct and surrounding border heart 
tissues were chopped into small pieces and digested in 
collagenase D and DNase 1 (2.5 mg/mL collagenase D; 
60 U/mL DNAse 1; Ambion) in HBSS (GIBCO; Thermo 
Fisher) at 37°C for 30 min following dissociation by 
gentleMacs Dissociator (according to manufacturer’s 
instructions; Miltenyi; Surrey, UK). The digested tissue 
was gently disaggregated and filtered through a 30 µm cell 
strainer to remove larger cells (including cardiomyocyes). 
Cells were then centrifuged at 300 g for 5 min and washed 
in PBS. Cardiac fibroblasts were isolated magnetically 
using a Miltenyi neonatal cardiac fibroblast isolation kit 
(MACS), according to manufacturer’s instructions.
Three cellular fractions were produced from 
this isolation method (Fractions 1–3). These were 
characterized by qPCR (Supplementary Fig.  4) and flow 
cytometry using specific cellular markers. Flow cytometry 
analysis revealed that Fraction 1 contained the highest 
levels of CD45 and platelet endothelial cell adhesion 
molecule (Pecam1; CD31; data not shown) suggesting 
enrichment for leukocytes (Nakano  et  al. 1990) and 
endothelial cells, respectively (Newman 1997), and 
this was confirmed by qPCR analysis (Supplementary 
Fig. 4). Fraction 2 highly expressed the fibroblast markers 
Discoidin domain receptor 2 (Ddr2; Supplementary Fig. 4) 
and type 1 collagen A1 (Col1a1; Supplementary Fig.  4), 
suggesting that it was enriched for fibroblasts. Fraction 3, 
which highly expressed Thy1 cell surface antigen (Thy-1; 
CD90), was also positive for the cardiac fibroblast markers 
Ddr2 and Col1a1 (Supplementary Fig.  4). In the heart, 
DDR2 is the most specific marker of cardiac fibroblasts 
(Camelliti  et  al. 2005). Thy1 is only expressed by a 
subset of fibroblasts (Willis et al. 1994). All isolated Ddr2 
and Col1a1 (Ddr2+Col1a1+)-expressing cells (Fractions 
2; Thy1low and 3; Thy1high) were considered enriched 
for fibroblasts, and Fraction 1 enriched for leukocytes 
and endothelial cells. These cellular fractions from WT 
and Hsd11b1−/− mice were analyzed by qPCR for the 
Table 1 Antibodies.
Name and clone Conjugate Dilution Supplier and cat #
Primary antibodies
 Rat anti-mouse Gr1 (Ly6G and Ly6C) None 1:100 BD Pharmingen #550291
 Clone RB6-8C5    
 Mouse anti-mouse CD45 PE Cy7 1:100 Biolegend #109830
 Clone 105    
 Rat anti-mouse CD11b Alexafluor 700 1:100 Biolegend #101222
 Clone M1/70    
 Rat anti-mouse Ly6G Pacific Blue 1:100 Biolegend #127612
 Clone 1A8    
 Rat anti-mouse CXCR4 Alexafluor 647 1:100 Biolegend #129201
 Clone TG12/CXCR4    
 Anti-mouse CXCR2 PerCp cy5.5 1:100 Biolegend #129103
 Clone TG11/CXCR2    
 Sheep anti-mouse 11β-HSD1 None 1:100 In house
Secondary antibodies
 Rabbit anti-rat IgG Biotin 1:200 Vector # BA4001
 Donkey anti-sheep Alexa Fluor 488 1:100 Abcam # ab150177
Table 2 Applied Biosystems gene expression arrays used.
 
Gene name
TAQman gene 
expression array
Glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh)
Mm99999915_gl
CXCL1 (Cxcl1) Mm004207460_m1
NLRP3 (Nlrp3) Mm04210225_m1
Chemokine (C-C motif) ligand 3 (Ccl3) Mm00441259_g1
L-selectin Mm00441291_m1
CXCL5 (Cxcl5) Mm004 36451_g1
Interleukin (IL-)1β (Il1b) Mm00434228_m1
IL-6 (Il6) Mm00446190_m1
CXCL2 (Cxcl2) Mm00436450_m1
Growth differentiation factor 15 (Gdf15) Mm00442228_m1
CXCL12 (Cxcl12) Mm00445553_m1
11βHSD1 (Hsd11b1) Mm 00476182_m1
Thy1 (Yhy1) Mm00493682_g1
CD31 (Pecam1) Mm01242584_m1
DDR2 (Ddr2) Mm00445615_m1
Col1a1 (Col1a1) Mm00801666_g1
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production of various genes of interest (Table  2). qPCR 
data were also analyzed on fractions enriched for both 
Thy1low and Thy1high fibroblasts from WT mice alone post 
MI (Supplementary Fig. 5).
Cardiac fibroblast culture
Mice were killed by exposure to increasing concentrations 
of CO2. Cardiac fibroblasts were collected from hearts by 
collagenase digestion and cultured as described previously 
for human cells (Turner  et  al. 2003). Briefly, ventricular 
tissue from 6- to 8-week-old mice was washed in PBS, 
and then minced with scissors and digested by adding 
Worthington Type II collagenase (600 IU/mL) for 90 min 
with occasional shaking at 37°C. After centrifugation of 
the suspension, the cells were washed twice in DMEM 
cell culture medium, before seeding cells into a T25 tissue 
culture flask. Non-adherent cells were removed after 
30 min, and the remaining cells were incubated with 
full growth medium (DMEM + 10% FCS; Thermo Fisher) 
overnight. The next day, cells were washed twice with PBS 
to remove any residual blood cells before the addition of 
fresh growth medium. For experiments, cells at passages 1–2 
were plated into 6-well plates and serum-starved overnight 
before incubation for 24 h with medium containing 1 ng/
mL IL-1α together with 200 nM corticosterone, 200 nM 
11-dehydrocoticosterone (11-DHC; inert form) or ethanol 
(vehicle control). Conditioned media were collected for 
ELISA analysis. RNA was extracted from cell pellets and 
cDNA synthesized for qPCR as described (Turner  et  al. 
2007) (TaqMan gene expression arrays; Table 2).
Chemokine quantification from fibroblast 
culture supernatant
ELISAs for CXCL2 and CXCL5 in conditioned media 
from fibroblast cultures were carried out according to 
manufacturer’s instructions (R&D Systems).
RNA extraction and quantitative PCR (qPCR)
RNA was extracted from bone marrow, cardiac left 
ventricular/infarct tissue or fibroblast cell fractions 
using the TRIzol method (according to manufacturers 
instructions; Thermo Fisher), and this was then reverse 
transcribed to cDNA (Applied Biosystems high-capacity 
cDNA reverse transcription kit or Promega reverse 
transcription system). TaqMan gene expression arrays 
(Applied Biosystems) were used to quantify mRNA 
expression of genes (Table  2). Results were normalized 
for GAPDH expression and presented as fold increases 
over average control level analyzed in parallel, unless 
otherwise stated.
Statistical analyses
All values are expressed as mean ± s.e.m. Unpaired Student’s 
t-test or ANOVA with Newman–Keuls post-hoc test 
were used for analysis. P values <0.05 denote statistical 
significance, *P < 0.05, **P < 0.01, ***P < 0.005.
Results
Global deletion of Hsd11b1 enhances neutrophil 
mobilization to blood and recruitment to the heart after 
MI, without changing infarct injury or plasma 
corticosterone concentration
Deletion of 11β-HSD1 in the hearts of Hsd11b1−/− 
mice was confirmed by qPCR (Supplementary Fig. 1A) 
and Western blot (Supplementary Fig.  1B). After 
induction of MI, initial cardiac damage was similar 
in WT and Hsd11b1−/− mice as measured by the 
concentration of troponin I in tail blood collected 
24 h post injury (Supplementary Fig.  1C). Analysis of 
hearts collected from these mice showed that Gr-1 
immunoreactive neutrophil content in the infarct and 
border of Hsd11b1−/− mice was significantly higher 
than that of WT (Fig.  1A and B; P < 0.05), confirming 
our previous observations (McSweeney  et  al. 2010). 
Flow cytometry revealed that blood from Hsd11b1−/− 
mice also contained significantly more neutrophils 
(CD45+CD11b+Ly6G+cells; Supplementary Fig.  2) 
post MI compared to WT (Fig.  1C,  P  < 0.05). Plasma 
corticosterone concentration in morning blood samples 
was increased to similar levels in WT and Hsd11b1−/− 
mice 24 h after induction of MI (Fig.  1D), excluding 
this as a contributing factor to alteration in neutrophil 
mobilization or recruitment.
Increased neutrophil mobilization to blood is associated 
with reduced neutrophil expression of CXCR4, but not 
CXCR2, on bone marrow and blood neutrophils
To investigate whether increased mobilization of 
neutrophils to the blood of Hsd11b1−/− mice could be 
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explained by changes in the expression of receptors 
determining retention or mobilization in the bone 
marrow, the surface expression of CXCR2 and CXCR4 
on neutrophils was determined by flow cytometry. The 
surface expression of CXCR4, a receptor involved in 
bone marrow retention of neutrophils (Eash et al. 2010), 
was found to be reduced on bone marrow neutrophils 
collected from Hsd11b1−/− mice after MI (Supplementary 
Fig.  3A; P < 0.05), but there was no change in surface 
expression of the receptor determining mobilization, 
CXCR2 (Supplementary Fig.  3C). Gene expression of 
Cxcl12 (SDF-1), the primary ligand for CXCR4, was not 
modified in the bone marrow of Hsd11b1−/− compared 
with WT (Supplementary Fig. 3B).
Increased neutrophil mobilization to blood depends on 
the absence of Hsd11b1 gene expression in host, not 
donor bone marrow-derived, cells in bone marrow 
chimeric mice
To investigate whether increased mobilization of 
neutrophils to the blood results from direct effects of 
Hsd11b1 deletion in neutrophils, bone marrow chimeric 
mice with Hsd11b1 deletion in either donor bone marrow 
cells (BMKO) or in host cells (Host KO) were prepared. 
For irradiation controls, WT bone marrow was transferred 
into irradiated WT hosts. Flow cytometric analysis of 
intracellular 11β-HSD1 protein in blood neutrophils 
confirmed appropriate removal. Irradiation control 
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Figure 1
Increased neutrophil mobilization and recruitment to the heart in Hsd11b1−/− mice post MI. (A) Representative images of Gr-1 IHC of day 2 infarcted 
hearts from both WT (left) and Hsd11b1−/− mice (right). (B) Analysis of the % Gr-1+ immunostaining in infarct and border regions of heart sections from 
Hsd11b1−/− vs WT animals (n = 7/5). (C) Neutrophil numbers in the blood of WT vs Hsd11b1−/− mice measured by flow cytometry at 1 day post MI (n = 4/3). 
(D) Plasma corticosteroid levels were raised post MI and did not differ between WT and Hsd11b1−/− mice (n = 7/6; dashed line represents level for naïve 
C57BL/6 mice, approx. 50–100 ng/mL). *P < 0.05.
Figure 2
Absence of gene expression in host cells in bone 
marrow chimera causes increased neutrophil 
mobilization but targeted deletion of Hsd11b1−/− 
in smooth muscle cells and cardiomyocytes does 
not affect neutrophil mobilization or recruitment 
post MI. Flow cytometric analysis confirms 
appropriate presence or absence of 11β-HSD1 in 
the neutrophils of chimeric mice (A). Blood 
neutrophil numbers were measured in chimeric 
mice (B; n = 7/6/6, P < 0.05). (C) Neutrophils present 
in the heart 2 days post MI in control 
(Hsd11b1CVCre−) vs experimental animals 
(Hsd11b1CVCre+). (D) Analysis of blood neutrophil 
numbers in control (Hsd11b1CVCre−) vs 
experimental animals (Hsd11b1CVCre+) at 1 day 
post MI. n = 4/4.
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and Host KO neutrophils were positive for 11β-HSD1 
expression, but BMKO neutrophils did not express this 
protein (dashed box; Fig.  2A). In these bone marrow 
chimeric mice, neutrophil mobilization to the blood 
was increased relative to irradiation control mice in host 
KO animals post MI (Fig. 2B; P < 0.05), but not in BMKO 
mice (Fig. 2B). These data suggest that it is Hsd11b1 in a 
component of the host tissue, rather than in bone marrow-
derived cells, that determines increased mobilization of 
neutrophils to the blood following MI.
11β-HSD1 deletion in cardiomyocytes and vascular 
smooth muscle cells does not influence neutrophil 
mobilization or accumulation in the myocardium
Cardiomyocytes and vascular smooth muscle are key 
sites of 11β-HSD1 expression in the heart. To investigate 
whether 11β-HSD1 activity here might account for 
enhanced neutrophil mobilization to the blood and 
recruitment to the heart, MI was induced in mice with 
targeted deletion of Hsd11b1 in smooth muscle and 
cardiomyocytes (White  et  al. 2016). However, floxed 
control, Hsd11b1CVCre− and Hsd11b1CVCre+ mice all had 
similar numbers of neutrophils in the heart (Fig. 2C) and 
blood (Fig. 2D) following coronary artery ligation.
11β-HSD1 deletion increases cardiac expression of a 
subset of neutrophil chemoattractant genes after MI
To investigate potential mediators of increased neutrophil 
recruitment to the heart, expression of a panel of genes 
encoding molecules known to regulate neutrophil 
recruitment was assessed in the left ventricle of hearts 
from Hsd11b1−/− and WT mice. Cardiac expression levels 
of genes encoding the neutrophil chemoattractants Cxcl1 
(KC) and Ccl3 (MIP-1α), as well as the inflammasome Nlrp3, 
and the adhesion molecule, L-selectin were all increased 
in hearts collected after MI relative to control hearts, 
but expression of these genes was not modified in hearts 
from Hsd11b1−/− mice relative to WT (Fig.  3A; P < 0.05). 
Expression of the neutrophil inhibitory peptide Gdf-
15 was also increased post MI, consistent with previous 
observations (Kempf  et  al. 2011), but was not modified 
in hearts from Hsd11b1−/− mice relative to WT (Fig. 3B). 
In contrast, expression of genes encoding Cxcl2 (MIP-2α), 
Cxcl5 (LIX), Il1b (IL-1β) and Il6 (IL-6) was increased in 
the heart after MI and further increased in hearts from 
Hsd11b1−/− mice compared to WT mice (Fig. 3C).
Cxcl2 and Cxcl5 expression is increased in fibroblasts 
isolated from infarcted hearts of mice deficient  
in 11β-HSD1
Cardiac fibroblasts express 11β-HSD1 (Furtado et al. 2014) 
and as ‘host’ cells in bone marrow chimera mice, it was 
reasoned that fibroblasts were a potential site for regulation 
of neutrophil chemoattractant expression in the infarcted 
heart. Three cellular fractions were isolated by magnetic 
bead separation (see ‘Materials and methods’ section and 
Supplementary Fig. 4) from the infarct and infarct border 
of hearts from WT and Hsd11b1−/− mice collected 24 h 
post MI. Cxcl2 was found to be preferentially expressed 
in the Ddr2+Col1a1+Thy1high fibroblast fraction from WT 
hearts (Fraction 3; Supplementary Fig. 5A; P < 0.01), and 
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Figure 3
Inflammatory cytokines and chemokines involved in neutrophil recruitment increase in the heart post MI. qPCR was carried out on infarct and border 
cardiac tissue from WT or Hsd11b1−/− mice 24 h post MI and compared to naïve WT ventricular tissue. (A) Cxcl1, NLRP2, Ccl3 and the adhesion molecule, 
L-selectin, increased in infarcted tissue compared to naïve myocardium but did not differ between WT and Hsd11b1−/− infarcts. (B) Expression of the 
neutrophil inhibitory peptide Gdf-15 was not modified in hearts from Hsd11b1−/− mice. (C) Cxcl2, Cxcl5, Il1b and Il6 were all expressed to a greater extent 
in Hsd11b1−/− than in WT infarct tissue. (C) *P < 0.05, **P < 0.01, ***P < 0.005. In representative experiments shown, n = 4/3, norm., normalized to GAPDH.
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expression was increased 10-fold in this cellular fraction 
when isolated from hearts of Hsd11b1−/− mice (Fraction 
3; Fig.  4A; P < 0.05). Cxcl5 was preferentially expressed 
by Ddr2+Col1a1+Thy1low fibroblast fraction (Fraction 2; 
Supplementary Fig.  5B; P < 0.005) and expression was 
significantly increased in fibroblasts isolated from hearts 
of Hsd11b1−/− mice relative to WT after MI (Fig.  4B; 
P < 0.01). Hsd11b1 was expressed in both fibroblast subsets 
following MI (Supplementary Fig.  6). Il-1 and Il-6 were 
expressed in Fraction 1 containing CD45+ leucocytes 
and CD31+ve endothelial cells, as well as in fibroblasts, 
but expression levels did not differ between WT and 
Hsd11b1−/− animals in any fraction (Fig. 4C and D).
11β-HSD1 regulates the expression of Cxcl2 and Cxcl5 by 
cardiac fibroblasts in vitro
To confirm a role for glucocorticoid regeneration in 
regulating chemokine expression in cardiac fibroblasts, 
fibroblasts were isolated from the hearts of WT mice, 
cultured in vitro and activated by exposure to IL-1α for 
24 h (Fig. 5). IL-1 induced an increase in the expression 
of Cxcl2 and Cxcl5 genes in cardiac fibroblasts (Fig. 5A) 
that was accompanied by increased secretion of 
CXCL2 and CXCL5 protein into the culture medium 
bathing these cells (Fig.  5C and D). Administration of 
corticosterone (200 nM) or of 11-dehydrocorticosterone 
(11-DHC; 200 nM), the product and substrate of 11β-HSD1, 
respectively, suppressed IL-1α-induced gene expression of 
Cxcl2 and Cxcl5 (Fig.  5B) and tended to reduce protein 
release (Fig.  5C and D). Although expression of Il6 was 
not modified in fibroblasts freshly isolated from the 
heart, it was significantly increased by IL-1α in cultured 
cells, and this was suppressed by corticosterone and 
11-DHC (Fig. 5E).
Discussion
Neutrophils are rapidly recruited to the heart following 
injury and are required for tissue repair (Frangogiannis 
2012, Yan  et  al. 2013), but regulation is essential as 
excessive or prolonged recruitment can result in increased 
tissue damage and impaired repair (Jordan  et  al. 1999, 
Ma  et  al. 2013). The results from the present study 
identify suppression of myocardial CXCL2 and CXCL5 
chemoattractant expression by 11β-HSD1 as a novel 
mechanism with potential for regulation of neutrophil 
recruitment to the injured myocardium following 
infarction. Furthermore, the data indicate that cardiac 
fibroblasts are a key site for glucocorticoid regeneration 
by 11β-HSD1 during acute inflammation following 
myocardial injury.
Glucocorticoids, released acutely from the adrenal 
glands after MI, not only have direct anti-inflammatory 
Figure 4
Cardiac fibroblasts express Cxcl2 and Cxcl5 post 
MI, which increase in the absence of intracellular 
glucocorticoid regeneration. qPCR analysis of 
Cxcl2 (A) and Cxcl5 (B), IL1b (C) and IL-6 (D) 
performed on RNA isolated from the cellular 
fractions 1–3 (Supplementary methods) in WT vs 
Hsd11b1−/− mice. *P < 0.05, **P < 0.01, n = 5–6 per 
group.
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effects, but also promote intracellular glucocorticoid 
regeneration from inert metabolites that enter cells from 
the circulation, thus amplifying their effects specifically 
in cells that express 11β-HSD1 (Chapman  et  al. 2013a, 
Gray  et  al. 2017). In the present study, systemic 
glucocorticoid was increased to the same extent in mice 
with and without 11β-HSD1 after MI; yet, in agreement 
with our previous observation (McSweeney  et  al. 2010), 
neutrophil recruitment to the heart was increased 
in the absence of 11β-HSD1. 11β-HSD1 deficiency or 
pharmacological inhibition similarly enhances neutrophil 
recruitment in other models of sterile inflammation, 
including arthritic joints, and in sterile peritonitis 
(Coutinho  et  al. 2012, Chapman  et  al. 2013b). Thus, 
intracellular regeneration of glucocorticoid in cells that 
express 11β-HSD1 promotes mechanisms that restrain 
neutrophil recruitment during inflammation.
Neutrophils express Hsd11b1 and expression is 
increased as they are recruited to sites of inflammation 
(Kardon  et  al. 2008, Coutinho  et  al. 2016). Alteration 
in the expression of neutrophil adhesion molecules, 
including L-selectin, was identified as a mechanism 
associated with increased neutrophil recruitment that 
accompanies pharmacological inhibition of 11β-HSD1 
in peritonitis (Coutinho et al. 2016). Such a mechanism 
could be involved in the post-MI heart, although 
expression of L-selectin was unchanged in hearts from 
Hsd11b1−/− mice relative to WT. Increased neutrophil 
content of myocardium post MI was matched by increased 
blood neutrophil numbers. Bone marrow neutrophils 
express 11β-HSD1 at a higher level during inflammation 
(Coutinho et al. 2016), and we considered the possibility 
that this could influence neutrophil egress from the bone 
marrow. Egress is regulated by the balance between the 
actions of release signals (e.g. CXCL1, CXCL5) interacting 
with neutrophil CXCR2 and pro-retention signals in 
the bone marrow, particularly CXCL12 interacting with 
CXCR4 (Eash et al. 2010). Flow cytometry revealed that 
CXCR2 on bone marrow neutrophils from Hsd11b1−/− 
mice post MI was not changed relative to WT but that 
expression of CXCR4 was reduced. Glucocorticoids 
upregulate CXCR4 expression on eosinophils and 
T-lymphocytes (Wang  et  al. 1998, Nagase  et  al. 2000), 
and this result suggests that glucocorticoid regenerated 
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Figure 5
Cultured cardiac fibroblast expression of Hsd11b1, Cxcl2, Cxcl5 and Il-6 in the presence or absence of IL-1α ± Cort or DHC. (A) qPCR analysis of Cxcl2 and 
Cxcl5 in cardiac fibroblasts cultured in the presence or absence of IL-1α for 24 h. (B) qPCR carried out on cardiac fibroblasts in the presence or absence of 
IL-1α ± corticosterone (Cort) or 11-DHC, expressed as fold change over IL-1α treatment alone. Protein production of CXCL2 (C) and CXCL5 (D) in the 
supernatants as measured by ELISA. (E) The influence of IL-1α ± corticosterone (Cort) or 11-DHC on expression of Il-6 by cultured mouse cardiac 
fibroblasts. *P < 0.05, **P < 0.01, ***P < 0.005. n = 3–5 per group.
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through 11β-HSD1 could engage a similar mechanism in 
neutrophils. However, in bone marrow chimeric mice, 
blood neutrophil numbers were increased in mice with 
‘host’ knockout of Hsd11b1, but not in mice with bone 
marrow cell knockout of 11β-HSD1. Therefore, although 
an influence of neutrophil 11β-HSD1 activity cannot be 
excluded, activity in ‘host’ cells seem to be more central to 
the promotion of neutrophil mobilization after MI. This 
could include the non-myeloid component of the bone 
marrow itself and, although 11β-HSD1 failed to influence 
the expression of the retention factor CXCL12 in the bone 
marrow stroma, this merits further investigation. 
The heart releases a number of CXCR2 ligands in 
response to injury (Frangogiannis 2012) and myocardial 
cells that express 11β-HSD1 likely represent a key ‘host’ 
component associated with the promotion of neutrophil 
mobilization post MI. Investigation of neutrophil 
chemoattractant expression revealed that while a number 
of these molecules, including Cxcl1/KC, were expressed at 
a higher level in the heart after MI, only a subset, including 
Cxcl2 and Cxcl5, IL-1 and Il-6 were further increased in 
hearts from Hsd11b1−/− mice. Transfer of bone marrow 
from Hsd11b1−/− mice replaced myeloid components of the 
myocardium without altering neutrophil mobilization, 
suggesting that any alteration in gene expression relevant 
to this outcome is in non-myeloid cells of the heart. 
These cells include cardiomyocytes (Mazancova  et  al. 
2005), smooth muscle cells (Hatakeyama et al. 2001) and 
fibroblasts (Sun & Myatt 2003). 11β-HSD1 enzyme activity 
is not detectable in endothelial cells (Christy et al. 2003, 
Dover  et  al. 2007). Neither mobilization to blood nor 
recruitment to the heart were increased following MI 
in mice with targeted deletion of Hsd11b1 in smooth 
muscle cells and cardiomyocytes, ruling out 11β-HSD1 in 
these cells as being key in the regulation of neutrophil 
recruitment. This is consistent with our previous 
observations that Hsd11b1 deletion in these cells did not 
influence angiogenesis or the development of heart failure 
following MI (White et al. 2016).
Fibroblasts are abundant in the heart (Shinde & 
Frangogiannis 2014). They have immunomodulatory roles 
in many sites of the body (Smith et al. 1997, Silzle et al. 
2004) regulating the types and functions of leukocytes 
recruited (Silzle  et  al. 2004). Cardiac fibroblasts secrete 
immunoactive molecules (Turner  et  al. 2011, Shinde & 
Frangogiannis 2014) and express 11β-HSD1 particularly 
highly (Furtado  et al. 2014). In synovial fibroblasts 11β-
HSD1 activity results in the suppression of inflammation 
associated with arthritis (Hardy  et  al. 2006, Hardy  et  al. 
2008, Ahasan  et  al. 2012). To investigate whether 11β-
HSD might have this role in the heart, Ddr2+Col1a1+ 
fibroblasts were isolated from the mouse heart post MI. 
Cardiac fibroblasts expressed varying levels of Thy1 and, 
interestingly, Cxcl2 expression was specifically increased 
in Thy1high fractions, whereas Cxcl5 expression was 
increased in the Thy1low fibroblast-enriched fraction. 
Hsd11b1 expression was confirmed in both fractions 
(Fig.  6). Pro-inflammatory cytokines downregulate 
fibroblast Thy1 expression (Hagood  et  al. 2005), and 
differences in cell expression may indicate subsets that 
Figure 6
Schema for the regulation of neutrophil recruitment to the heart by 11β-HSD1. (A) Chemokines produced by fibroblasts in response to pro-inflammatory 
cytokines recruit neutrophils to the heart post MI (1). Thy1high and Thy1low cardiac fibroblasts preferentially produce CXCL2 and CXCL5, respectively (2). 
11β-HSD1 catalyzes the regeneration of local glucocorticoid, dampening chemokine expression (3). Circulating corticosterone and IL-1α from necrotic 
cardiomyocytes increase 11β-HSD1 expression (4). (B) In the absence of 11β-HSD1, fibroblasts are driven to produce excess CXCL2 and CXCL5 (5), 
unleashed due to the lack of dampening local glucocorticoid (6), driving increased neutrophil recruitment to the infarcted heart (7).
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have been exposed to different levels of cytokine or are 
in different states of activation in the healing infarct. Like 
Cxcl2 and Cxcl5, Il1b and Il6 expression was increased 
more in hearts from Hsd11b1−/− mice after MI. Cultured 
human cardiac fibroblasts produce IL-1 and IL-6 in 
culture (Turner  et  al. 2007) and 11β-HSD1 was able to 
regulate the expression of Il6 in cultured mouse cardiac 
fibroblasts in this study, as it does in cultured fibroblasts 
from other tissues (Hardy  et  al. 2006). However, there 
was no evidence for specific regulation of Il1 or Il6 
expression by 11β-HSD1 in fibroblasts freshly isolated 
from the infarcted heart. This could reflect differences in 
the environment and in fibroblast phenotype in situ in 
the heart 24 h after induction of MI, compared to culture 
conditions. In fact, expression of Il1b and Il6 in the cell 
fraction containing CD45+ve cells suggests that increased 
representation of mRNA from the increased number of 
recruited inflammatory cells in Hsd11b1−/− relative to WT 
hearts is more likely to account for their higher expression 
in intact hearts from Hsd11b1−/− mice.
IL-1α is induced early after ischemic injury in the 
heart, particularly by necrotic cardiomyocytes (Fig.  6) 
(Lugrin  et  al. 2015), and IL-1 receptor signaling is 
hypothesized to be critically important in regulating 
inflammatory pathways in the healing infarct, including 
promotion of pro-inflammatory cytokine release 
(Turner 2014). In cultured murine cardiac fibroblasts 
stimulated with IL-1α, provision of either corticosterone 
or 11-dehydrocorticosterone, the substrate for 11β-HSD1, 
decreased Cxcl2 and Cxcl5 expression, consistent with 
the regulation of gene expression secondary to 11β-
HSD1 activity in these cells (Fig.  6). Cxcl2 expression is 
known to be repressed by GR activation (Uhlenhaut et al. 
2013), and Cxcl5 was first described in mouse fibroblasts 
as a glucocorticoid-attenuated response gene (GARG) 
(Smith & Herschman 1996). Importantly, dampening 
of CXCL2 (Montecucco  et  al. 2013) and of CXCL5 
(Chandrasekar et al. 2001) is known to reduce neutrophil-
mediated tissue injury post MI. In future, it may be of 
value to further investigate the specific role of stromal 
cells in regulating neutrophil recruitment via these 
mediators, for example using an in vitro co-culture system 
(Munir et al. 2016).
Suppression of neutrophil recruitment is likely to 
be beneficial in terms of limiting acute injury to the 
myocardium, particularly following reperfusion. However, 
neutrophils secrete gelatinase-associated lipocalin that 
promotes macrophage polarization toward a pro-repair 
phenotype (Chen  et  al. 2014, Horckmans  et  al. 2017) 
and acquisition of this phenotype is also enhanced 
by efferocytosis of apoptotic neutrophils (Chen  et  al. 
2014). Macrophage polarization toward a reparative 
‘M2’ phenotype is enhanced in 11βHSD1-deficient mice 
during wound healing (McSweeney et al. 2010), and this 
associates with improved long-term functional outcome 
(White et al. 2016). Thus, early promotion of neutrophil 
recruitment to the myocardium may contribute to 
enhancement of tissue repair when 11β-HSD1 activity is 
lost. Alternatively, changes in the fibroblasts secretome 
under the influence of 11β-HSD1 may directly influence 
macrophage polarization status. While these data are 
supportive of cardiac fibroblasts as a key site for regulation 
of acute inflammation following myocardial injury, this 
mechanism needs to be more thoroughly tested in mice 
with fibroblast specific Hsd11b1 deletion. Targeting Cre-
Lox-mediated gene deletion specifically to fibroblasts has 
proved difficult in the past due to the lack of sufficiently 
selective Cre− mouse lines. However, Col1a2 Cre has 
recently been applied successfully to target fibroblasts 
during myocardial infarct healing (Duan et al. 2012), and 
in future, this approach will provide a means for testing 
the importance of Hsd11b1 in fibroblasts, and other 
mesenchymal cells, post MI.
In conclusion, these data are consistent with a novel 
role for 11β-HSD1 in the regulation of acute inflammation 
following MI, via suppression of CXCL2 and CXCl5 
chemoattractant expression and are supportive of cardiac 
fibroblasts as a key site for glucocorticoid regeneration by 
11β-HSD1 following myocardial injury.
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